CEVEC Pharmaceuticals GmbH

CEVEC is a biotechnology company specialized in cell line and process development for the scalable production of high-end biologics, including gene therapy vectors and complex glycosylated recombinant proteins, from R&D to production scale.

With CAP-Go, CEVEC enables theefficient production of complex recombinant proteins, like FVIII, C1-Inhibitor, laminins, A1AT and others, with high titers and excellent pharmacokinetics mediated by tailor-made glycosylation.

With CAP-GT, CEVEC has developed a scalable platform for gene therapy vector manufacturing based on suspension cell lines. For AAV (Adeno-Associated Viral) vectors CEVEC offers a unique fully scalable, stable helper virus-free production system.

CEVEC Pharmaceuticals at a glance:

Field of Activity
Development, services and licensing of human cell-based production platforms for biopharmaceuticals.
Ownership Structure and Financing Privately owned. Investors include Peppermint Venture Partners, Creathor Venture, NRW.Bank, KfW Bank, G.A.T. Holding, and others.
Partners Selected license partners: Beckmann Research Institute/City of Hope, Biotest, CSL Limited, medac, Provecs Medical, BioLamina, CellGenix; CDMO partners: Paragon Bioservices Inc., GenIbet Biopharmaceuticals
Technology and Unique Selling Point CEVEC’s CAP®-platforms for complex proteins and viral vectors used as therapeutics and in gene therapy applications are based on its proprietary CAP®-Technology, a unique expression system using human suspension cells.
• Fully scalable and cost-efficient
• GMP compatible process development from R&D to production scale
• Authentic tailor-made glycosylation (CAP-Go)
• Outstanding pharmacokinetic profi les and high yields of recombinant proteins
• Helper virus-free producer cell line for AAV vectors
Products / Services Cell line and process development and technology licensing for the manufacturing of tailor-made recombinant glycoproteins and gene therapy vectors from R&D to production scale.
Membership in networks / associations Bio Deutschland, Alliance for Regenerative Medicine (ARM), Dechema, BioRiver, Bio Cologne
Date of Incorporation  2003




Address Gottfried-Hagen-Straße 60-62
51105 Cologne
Telephone/Telefax +49 221 460 208-00/-01
E-Mail info@cevec.com
Web-Address www.cevec.com
Social Media LinkedIn



Business segment:
The expert in scalable, cost-effi cient
production of complex glycosylated
proteins and viral vectors.